Bringing the fundamentals into focus…
Back to Johnson & Johnson
How Johnson & Johnson stacks up
JNJ · against 1,215 other Healthcare companies
Growth
48/ 100
Below the middle of the pack.
Ranked #627 of 1,216 · scores higher than 48% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 40–49, including JNJ · Click a bar to see the companies
Why growth scores 48?
Weighted metrics compared with all Healthcare companies.A mix: stronger 3-year revenue growth, but weaker earnings per share growth than most Healthcare peers.
- slower growth in earnings per share: weaker than 68% of peers. Earnings per share growth: -7.2% vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 8.1% vs peer median 6.1%
- faster revenue growth over three years: stronger than 61% of peers. 3-year revenue growth: 9.3% vs peer median 5.8%
Metric by metric
Position: dot = JNJ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JNJ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,242 reported | 8.1% | 6.1% | 56% | 33% | |
| Earnings per share growthHigher is better · 676 reported | -7.2% | 9.7% | 32% | 33% | |
| 3-year revenue growthHigher is better · 1,193 reported | 9.3% | 5.8% | 61% | 33% |
Ranking by growth score
Top 5 and the companies ranked around JNJ| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.0B EUR (≈$3.3B) | 100 | 99 | |
| 1 | 577M USD | 100 | 53 | |
| 1 | 653M USD | 100 | 91 | |
| 4 | 10.2B HKD (≈$1.3B) | 99 | 62 | |
| 4 | 2.1B HKD (≈$264M) | 99 | 57 | |
| 627 | 1.3B SGD (≈$985M) | 48 | 35 | |
| 627 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score